Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Molecular and Cellular Biochemistry
|
August 19, 2024
SGLT2 inhibitors: how do they affect the cardiac cells
Betul Rabia Erdogan, Ebru Arioglu-Inan
Handbook of Experimental Pharmacology
|
July 13, 2023
Sex Differences in Glucose Homeostasis
Ebru Arioglu-Inan, Gizem Kayki-Mutlu
Handbook of Experimental Pharmacology
|
May 11, 2026
Cardiovascular Dysfunction in Type 2 Diabetes: The Role of MicroRNAs
Gizem Kayki-Mutlu, Ebru Arioglu-Inan
Neurourology and Urodynamics
|
March 31, 2025
β<sub>3</sub>-Adrenoceptor Agonist Effects on the Urinary Bladder Beyond Detrusor Relaxation
Martin C Michel, Ebru Arioglu-Inan, Martin Hennenberg
Cells
|
December 1, 2020
Expression and Signaling of β-Adrenoceptor Subtypes in the Diabetic Heart
Betul R Erdogan, Martin C Michel, Ebru Arioglu-Inan
British Journal of Pharmacology
|
February 26, 2019
Cardiac β<sub>3</sub> -adrenoceptors-A role in human pathophysiology?
Ebru Arioglu-Inan, Gizem Kayki-Mutlu, Martin C Michel
Neurourology and Urodynamics
|
February 3, 2018
A systematic review of urinary bladder hypertrophy in experimental diabetes: Part I. Streptozotocin-induced rat models
Ebru Arioglu Inan, Johanne H Ellenbroek, Martin C Michel
Neurourology and Urodynamics
|
August 29, 2018
A systematic review of urinary bladder hypertrophy in experimental diabetes: Part 2. Comparison of animal models and functional consequences
Johanne H Ellenbroek, Ebru Arioglu Inan, Martin C Michel
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
May 11, 2022
Established and emerging treatments for diabetes-associated lower urinary tract dysfunction
Betül R Erdogan, Guiming Liu, Ebru Arioglu-Inan, et al.
European Journal of Pharmacology
|
June 22, 2019
Beta-3 adrenoceptors: A potential therapeutic target for heart disease
Gizem Kayki-Mutlu, Irem Karaomerlioglu, Ebru Arioglu-Inan, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Molecular and Cellular Biochemistry
|
August 19, 2024
SGLT2 inhibitors: how do they affect the cardiac cells
Betul Rabia Erdogan, Ebru Arioglu-Inan
Handbook of Experimental Pharmacology
|
July 13, 2023
Sex Differences in Glucose Homeostasis
Ebru Arioglu-Inan, Gizem Kayki-Mutlu
Handbook of Experimental Pharmacology
|
May 11, 2026
Cardiovascular Dysfunction in Type 2 Diabetes: The Role of MicroRNAs
Gizem Kayki-Mutlu, Ebru Arioglu-Inan
Neurourology and Urodynamics
|
March 31, 2025
β<sub>3</sub>-Adrenoceptor Agonist Effects on the Urinary Bladder Beyond Detrusor Relaxation
Martin C Michel, Ebru Arioglu-Inan, Martin Hennenberg
Cells
|
December 1, 2020
Expression and Signaling of β-Adrenoceptor Subtypes in the Diabetic Heart
Betul R Erdogan, Martin C Michel, Ebru Arioglu-Inan
British Journal of Pharmacology
|
February 26, 2019
Cardiac β<sub>3</sub> -adrenoceptors-A role in human pathophysiology?
Ebru Arioglu-Inan, Gizem Kayki-Mutlu, Martin C Michel
Neurourology and Urodynamics
|
February 3, 2018
A systematic review of urinary bladder hypertrophy in experimental diabetes: Part I. Streptozotocin-induced rat models
Ebru Arioglu Inan, Johanne H Ellenbroek, Martin C Michel
Neurourology and Urodynamics
|
August 29, 2018
A systematic review of urinary bladder hypertrophy in experimental diabetes: Part 2. Comparison of animal models and functional consequences
Johanne H Ellenbroek, Ebru Arioglu Inan, Martin C Michel
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
May 11, 2022
Established and emerging treatments for diabetes-associated lower urinary tract dysfunction
Betül R Erdogan, Guiming Liu, Ebru Arioglu-Inan, et al.
European Journal of Pharmacology
|
June 22, 2019
Beta-3 adrenoceptors: A potential therapeutic target for heart disease
Gizem Kayki-Mutlu, Irem Karaomerlioglu, Ebru Arioglu-Inan, et al.
Page
of 3